Neurotrope Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Patients with Alzheimer's Disease

Author's Avatar
May 28, 2020
Article's Main Image

- New Phase 2 Study to Be Conducted in Collaboration with NIH Under a $2.7 Million Grant -

- Management to Host Investor Conference Call and Webcast Today at 11:00 AM ET -

PR Newswire